| CXW CoreCivic | $14.84 -1.1%
 | 2/9/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $17.00 -> $18.00 | Low | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 2/9/2024 | 
| AFRM Affirm | $43.86 -10.9%
 | 2/9/2024 | Reiterated by | Wedbush | - | Underperform -> Underperform | $20.00 | Low | View details for Wedbush rating of Affirm (NASDAQ:AFRM) on 2/9/2024 | 
| ROKU Roku | $95.80 +1.2%
 | 2/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $120.00 | Low | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 2/9/2024 | 
| TTWO Take-Two Interactive Software | $154.91 -8.7%
 | 2/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $190.00 | Low | View details for Wedbush rating of Take-Two Interactive Software (NASDAQ:TTWO) on 2/9/2024 | 
| EXPE Expedia Group | $131.11 -17.8%
 | 2/9/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $130.00 | Low | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 2/9/2024 | 
| PINS Pinterest | $36.87 -9.5%
 | 2/9/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $35.00 -> $38.00 | Low | View details for Wedbush rating of Pinterest (NYSE:PINS) on 2/9/2024 | 
|  | 
| PEP PepsiCo | $167.67 -3.6%
 | 2/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $195.00 | Low | View details for Wedbush rating of PepsiCo (NASDAQ:PEP) on 2/9/2024 | 
| ORLY O'Reilly Automotive | $1,025.82 +0.5%
 | 2/8/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $940.00 -> $1,100.00 | Low | View details for Wedbush rating of O’Reilly Automotive (NASDAQ:ORLY) on 2/8/2024 | 
| SIMO Silicon Motion Technology | $68.46 +0.8%
 | 2/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $85.00 | Low | View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 2/8/2024 | 
| RBLX Roblox | $44.40 -1.0%
 | 2/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $53.00 -> $56.00 | Low | View details for Wedbush rating of Roblox (NYSE:RBLX) on 2/8/2024 | 
| QLYS Qualys | $171.85 +1.3%
 | 2/8/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $230.00 -> $210.00 | Low | View details for Wedbush rating of Qualys (NASDAQ:QLYS) on 2/8/2024 | 
| PYPL PayPal | $58.91 +5.0%
 | 2/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $85.00 | Low | View details for Wedbush rating of PayPal (NASDAQ:PYPL) on 2/8/2024 | 
| ASND Ascendis Pharma A/S | $141.75 +1.8%
 | 2/8/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $207.00 -> $225.00 | Low | View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 2/8/2024 | 
| PCRX Pacira BioSciences | $28.78 +3.9%
 | 2/8/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $57.00 | Low | View details for Wedbush rating of Pacira BioSciences (NASDAQ:PCRX) on 2/8/2024 | 
| GPRO GoPro | $2.57 -0.4%
 | 2/8/2024 | Downgraded by | Wedbush | Analyst A. Reese | Outperform -> Neutral | $4.00 -> $2.00 | Low | View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 2/8/2024 | 
| CMG Chipotle Mexican Grill | $2,638.35 +0.7%
 | 2/7/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Neutral -> Neutral | $2,400.00 | Low | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 2/7/2024 | 
| TXRH Texas Roadhouse | $134.73 -0.6%
 | 2/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $130.00 -> $145.00 | Low | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 2/7/2024 | 
| WEN Wendy's | $19.32 +1.3%
 | 2/7/2024 | Target Lowered by | Wedbush | Analyst N. Setyan | Neutral -> Neutral | $21.00 -> $20.00 | Low | View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 2/7/2024 | 
| CRSR Corsair Gaming | $13.24 +1.9%
 | 2/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $21.00 | Low | View details for Wedbush rating of Corsair Gaming (NASDAQ:CRSR) on 2/7/2024 | 
| SHOO Steven Madden | $41.75 +1.9%
 | 2/7/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $36.00 -> $38.00 | Low | View details for Wedbush rating of Steven Madden (NASDAQ:SHOO) on 2/7/2024 | 
| RLYB Rallybio | $1.77 +3.5%
 | 2/7/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $14.00 -> $13.00 | Low | View details for Wedbush rating of Rallybio (NASDAQ:RLYB) on 2/7/2024 | 
| VFC V.F. | $15.30 -0.3%
 | 2/7/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $16.50 -> $15.50 | Low | View details for Wedbush rating of V.F. (NYSE:VFC) on 2/7/2024 | 
| CRNC Cerence | $16.67 +5.5%
 | 2/7/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $19.00 -> $21.00 | N/A | View details for Wedbush rating of Cerence (NASDAQ:CRNC) on 2/7/2024 | 
| CHKP Check Point Software Technologies | $164.31 +0.7%
 | 2/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $170.00 -> $185.00 | Low | View details for Wedbush rating of Check Point Software Technologies (NASDAQ:CHKP) on 2/7/2024 | 
| TENB Tenable | $51.89 +2.3%
 | 2/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $50.00 -> $65.00 | Low | View details for Wedbush rating of Tenable (NASDAQ:TENB) on 2/7/2024 | 
| FTNT Fortinet | $70.44 +3.8%
 | 2/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $75.00 -> $86.00 | Low | View details for Wedbush rating of Fortinet (NASDAQ:FTNT) on 2/7/2024 | 
| SKY Skyline Champion | $81.17 +2.1%
 | 2/6/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $72.00 | Low | View details for Wedbush rating of Skyline Champion (NYSE:SKY) on 2/6/2024 | 
| LGIH LGI Homes | $120.79 +1.5%
 | 2/6/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $97.00 | Low | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 2/6/2024 | 
| RANI Rani Therapeutics | $3.79 -0.3%
 | 2/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $8.00 | Low | View details for Wedbush rating of Rani Therapeutics (NASDAQ:RANI) on 2/6/2024 | 
| PLTR Palantir Technologies | $24.38 -0.5%
 | 2/6/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $25.00 -> $30.00 | Low | View details for Wedbush rating of Palantir Technologies (NYSE:PLTR) on 2/6/2024 | 
| VRNS Varonis Systems | $51.98 +2.5%
 | 2/6/2024 | Upgraded by | Wedbush | Analyst D. Ives | Neutral -> Outperform | $35.00 -> $65.00 | Low | View details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 2/6/2024 | 
| MCD McDonald's | $289.47 -0.8%
 | 2/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $330.00 | Low | View details for Wedbush rating of McDonald’s (NYSE:MCD) on 2/6/2024 | 
| ACET Adicet Bio | $3.27 -3.3%
 | 2/5/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | Low | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 2/5/2024 | 
| BPMC Blueprint Medicines | $76.54 +3.2%
 | 2/5/2024 | Reiterated by | Wedbush | - | Outperform | $97.00 | Low | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 2/5/2024 | 
| GPRO GoPro | $2.57 -0.4%
 | 2/2/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 -> $4.00 | Low | View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 2/2/2024 | 
| META Meta Platforms | $468.11 -0.4%
 | 2/2/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $420.00 -> $520.00 | Low | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 2/2/2024 | 
| DECK Deckers Outdoor | $845.22 +1.5%
 | 2/2/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $825.00 -> $895.00 | Low | View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 2/2/2024 | 
| BZH Beazer Homes USA | $29.35 -0.3%
 | 2/2/2024 | Target Raised by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $32.00 -> $33.00 | Low | View details for Wedbush rating of Beazer Homes USA (NYSE:BZH) on 2/2/2024 | 
| SKX Skechers U.S.A. | $58.91 +1.6%
 | 2/2/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $75.00 -> $68.00 | Low | View details for Wedbush rating of Skechers U.S.A. (NYSE:SKX) on 2/2/2024 | 
| TSCO Tractor Supply | $235.08 +1.4%
 | 2/2/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $200.00 -> $235.00 | Low | View details for Wedbush rating of Tractor Supply (NASDAQ:TSCO) on 2/2/2024 | 
|  | 
| AMZN Amazon.com | $174.45 +2.7%
 | 2/2/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $210.00 -> $220.00 | Low | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 2/2/2024 | 
| MTH Meritage Homes | $154.42 -0.1%
 | 2/1/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $170.00 | Low | View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 2/1/2024 | 
| TCRX TScan Therapeutics | $5.81 -3.2%
 | 2/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $9.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 2/1/2024 | 
| NYCB New York Community Bancorp | $4.90 +16.9%
 | 2/1/2024 | Reiterated by | Wedbush | Analyst D. Chiaverini | Underperform -> Underperform | $6.00 | Low | View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 2/1/2024 | 
| CCS Century Communities | $88.04 +0.7%
 | 2/1/2024 | Target Raised by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $81.00 -> $92.00 | Low | View details for Wedbush rating of Century Communities (NYSE:CCS) on 2/1/2024 | 
| RBLX Roblox | $44.40 -1.0%
 | 1/31/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $53.00 | Low | View details for Wedbush rating of Roblox (NYSE:RBLX) on 1/31/2024 | 
| PHM PulteGroup | $103.10 -0.2%
 | 1/31/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $85.00 | Low | View details for Wedbush rating of PulteGroup (NYSE:PHM) on 1/31/2024 | 
| ARE Alexandria Real Estate Equities | $116.20 -1.4%
 | 1/31/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $140.00 | Low | View details for Wedbush rating of Alexandria Real Estate Equities (NYSE:ARE) on 1/31/2024 | 
| LC LendingClub | $8.63 +0.5%
 | 1/31/2024 | Reiterated by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $11.00 | Low | View details for Wedbush rating of LendingClub (NYSE:LC) on 1/31/2024 | 
| AX Axos Financial | $51.29 +1.9%
 | 1/31/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $59.00 -> $62.00 | Low | View details for Wedbush rating of Axos Financial (NYSE:AX) on 1/31/2024 | 
| HOPE Hope Bancorp | $10.79 +1.7%
 | 1/31/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $13.00 -> $12.00 | Low | View details for Wedbush rating of Hope Bancorp (NASDAQ:HOPE) on 1/31/2024 | 
| GOOGL Alphabet | $149.00 +2.1%
 | 1/31/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $160.00 | Low | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 1/31/2024 | 
| VFC V.F. | $15.30 -0.3%
 | 1/31/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $15.00 -> $16.50 | Low | View details for Wedbush rating of V.F. (NYSE:VFC) on 1/31/2024 | 
| AMD Advanced Micro Devices | $172.48 +1.8%
 | 1/31/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $200.00 | Low | View details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 1/31/2024 | 
| TSLA Tesla | $193.57 +2.1%
 | 1/31/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $315.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 1/31/2024 | 
| GM General Motors | $38.56 -0.2%
 | 1/31/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $40.00 -> $45.00 | Low | View details for Wedbush rating of General Motors (NYSE:GM) on 1/31/2024 | 
| EA Electronic Arts | $140.61 +1.3%
 | 1/31/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $162.00 | Low | View details for Wedbush rating of Electronic Arts (NASDAQ:EA) on 1/31/2024 | 
| SBUX Starbucks | $97.30 +0.7%
 | 1/31/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $95.00 | Low | View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 1/31/2024 | 
| BKNG Booking | $3,758.18 -2.1%
 | 1/30/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $3,850.00 | Low | View details for Wedbush rating of Booking (NASDAQ:BKNG) on 1/30/2024 | 
| ABNB Airbnb | $147.60 -2.0%
 | 1/30/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $135.00 -> $150.00 | Low | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 1/30/2024 | 
| HMST HomeStreet | $12.58 +0.4%
 | 1/30/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $15.00 -> $16.00 | Low | View details for Wedbush rating of HomeStreet (NASDAQ:HMST) on 1/30/2024 | 
| PPBI Pacific Premier Bancorp | $24.36 +1.2%
 | 1/30/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $31.00 -> $30.00 | Low | View details for Wedbush rating of Pacific Premier Bancorp (NASDAQ:PPBI) on 1/30/2024 | 
| RCUS Arcus Biosciences | $15.81 +3.9%
 | 1/30/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $36.00 -> $30.00 | Low | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 1/30/2024 | 
| INZY Inozyme Pharma | $5.82 +6.8%
 | 1/30/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $15.00 | Low | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 1/30/2024 | 
| PEPG PepGen | $14.66 -2.8%
 | 1/30/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $21.00 | Low | View details for Wedbush rating of PepGen (NASDAQ:PEPG) on 1/30/2024 | 
| ATXS Astria Therapeutics | $15.00 -1.7%
 | 1/30/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Astria Therapeutics (NASDAQ:ATXS) on 1/30/2024 | 
| SMCI Super Micro Computer | $740.29 +6.1%
 | 1/30/2024 | Target Raised by | Wedbush | Analyst M. Bryson | Neutral -> Neutral | $250.00 -> $530.00 | Low | View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 1/30/2024 | 
| AAPL Apple | $188.85 +0.3%
 | 1/30/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 1/30/2024 | 
| SQ Block | $66.88 -2.8%
 | 1/30/2024 | Upgraded by | Wedbush | Analyst M. Katri | Neutral -> Outperform | $70.00 -> $90.00 | Low | View details for Wedbush rating of Block (NYSE:SQ) on 1/30/2024 | 
| SRPT Sarepta Therapeutics | $126.87 -0.4%
 | 1/29/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $224.00 | Low | View details for Wedbush rating of Sarepta Therapeutics (NASDAQ:SRPT) on 1/29/2024 | 
| FCNCA First Citizens BancShares | $1,494.81 +1.1%
 | 1/29/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $1,800.00 | Low | View details for Wedbush rating of First Citizens BancShares (NASDAQ:FCNCA) on 1/29/2024 | 
| MSFT Microsoft | $420.55 +1.6%
 | 1/29/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $450.00 | Low | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 1/29/2024 | 
| CELH Celsius | $58.39 -0.5%
 | 1/29/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $75.00 | Low | View details for Wedbush rating of Celsius (NASDAQ:CELH) on 1/29/2024 | 
| BKU BankUnited | $26.79 +3.0%
 | 1/29/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $34.00 -> $31.00 | Low | View details for Wedbush rating of BankUnited (NYSE:BKU) on 1/29/2024 | 
| V Visa | $276.43 +0.2%
 | 1/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $270.00 -> $280.00 | Low | View details for Wedbush rating of Visa (NYSE:V) on 1/26/2024 | 
| INTC Intel | $43.31 +1.9%
 | 1/26/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $45.00 -> $40.00 | Low | View details for Wedbush rating of Intel (NASDAQ:INTC) on 1/26/2024 | 
| JACK Jack in the Box | $77.27 +0.2%
 | 1/26/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $83.00 | Low | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 1/26/2024 | 
| CUBI Customers Bancorp | $51.54 +2.4%
 | 1/26/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $70.00 -> $65.00 | Low | View details for Wedbush rating of Customers Bancorp (NYSE:CUBI) on 1/26/2024 | 
| CFR Cullen/Frost Bankers | $103.18 +1.4%
 | 1/26/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $115.00 | Low | View details for Wedbush rating of Cullen/Frost Bankers (NYSE:CFR) on 1/26/2024 | 
| FFWM First Foundation | $8.30 +1.3%
 | 1/26/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Neutral -> Neutral | $10.00 -> $11.00 | Low | View details for Wedbush rating of First Foundation (NASDAQ:FFWM) on 1/26/2024 | 
| ALPN Alpine Immune Sciences | $29.04 +2.2%
 | 1/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $26.00 -> $35.00 | Low | View details for Wedbush rating of Alpine Immune Sciences (NASDAQ:ALPN) on 1/26/2024 | 
| FUSN Fusion Pharmaceuticals | $11.57 +2.2%
 | 1/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 1/26/2024 | 
| VERA Vera Therapeutics | $43.21 +15.0%
 | 1/26/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $16.00 -> $21.00 | Low | View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 1/26/2024 | 
| DNTH Dianthus Therapeutics | $23.94 +3.2%
 | 1/26/2024 | Target Raised by | Wedbush | Analyst L. Chico | Outperform -> Outperform | $23.00 -> $24.00 | Low | View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 1/26/2024 | 
| BANC Banc of California | $13.24 +2.2%
 | 1/26/2024 | Target Raised by | Wedbush | Analyst D. Chiaverini | Neutral -> Neutral | $14.00 -> $16.00 | Low | View details for Wedbush rating of Banc of California (NYSE:BANC) on 1/26/2024 | 
| VLY Valley National Bancorp | $8.43 +2.3%
 | 1/26/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $12.00 -> $11.00 | Low | View details for Wedbush rating of Valley National Bancorp (NASDAQ:VLY) on 1/26/2024 | 
| STX Seagate Technology | $89.41 +2.0%
 | 1/25/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $100.00 | Low | View details for Wedbush rating of Seagate Technology (NASDAQ:STX) on 1/25/2024 | 
| DECK Deckers Outdoor | $845.22 +1.5%
 | 1/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $705.00 -> $825.00 | Low | View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 1/25/2024 | 
| CVBF CVB Financial | $17.18 +0.4%
 | 1/25/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $22.00 -> $21.00 | Low | View details for Wedbush rating of CVB Financial (NASDAQ:CVBF) on 1/25/2024 | 
| COLB Columbia Banking System | $18.84 +0.3%
 | 1/25/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $29.00 -> $24.00 | Low | View details for Wedbush rating of Columbia Banking System (NASDAQ:COLB) on 1/25/2024 | 
|  | 
| LRN Stride | $62.55 +4.0%
 | 1/24/2024 | Reiterated by | Wedbush | - | Outperform |  | Low | View details for Wedbush rating of Stride (NYSE:LRN) on 1/24/2024 | 
| NFLX Netflix | $561.32 +0.5%
 | 1/24/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $525.00 -> $615.00 | Low | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 1/24/2024 | 
| HAFC Hanmi Financial | $15.47 +4.1%
 | 1/24/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $21.00 -> $20.00 | Low | View details for Wedbush rating of Hanmi Financial (NASDAQ:HAFC) on 1/24/2024 | 
| EWBC East West Bancorp | $69.41 +0.3%
 | 1/24/2024 | Reiterated by | Wedbush | Analyst D. Chiaverini | Outperform -> Outperform | $86.00 | Low | View details for Wedbush rating of East West Bancorp (NASDAQ:EWBC) on 1/24/2024 | 
| PRPL Purple Innovation | $1.40 +8.5%
 | 1/24/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $1.25 | Low | View details for Wedbush rating of Purple Innovation (NASDAQ:PRPL) on 1/24/2024 | 
| BBY Best Buy | $75.60 +0.1%
 | 1/24/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $70.00 -> $75.00 | Low | View details for Wedbush rating of Best Buy (NYSE:BBY) on 1/24/2024 | 
| LOGI Logitech International | $85.21 +0.7%
 | 1/24/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $90.00 -> $92.00 | Low | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 1/24/2024 | 
| SRRK Scholar Rock | $15.40 -2.0%
 | 1/23/2024 | Reiterated by | Wedbush | - | Outperform | $23.00 | Low | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 1/23/2024 | 
| DHI D.R. Horton | $144.91 +0.2%
 | 1/23/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $115.00 | Low | View details for Wedbush rating of D.R. Horton (NYSE:DHI) on 1/23/2024 | 
| IMNM Immunome | $23.11 -1.6%
 | 1/23/2024 | Target Raised by | Wedbush | Analyst D. Nierengarten | Outperform -> Outperform | $12.00 -> $19.00 | Low | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 1/23/2024 | 
| ZION Zions Bancorporation, National Association | $40.09 +0.5%
 | 1/23/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $48.00 -> $46.00 | Low | View details for Wedbush rating of Zions Bancorporation, National Association (NASDAQ:ZION) on 1/23/2024 | 
| TSLA Tesla | $193.57 +2.1%
 | 1/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $350.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 1/23/2024 | 
| KEY KeyCorp | $13.89 +0.1%
 | 1/19/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $16.00 -> $14.00 | Low | View details for Wedbush rating of KeyCorp (NYSE:KEY) on 1/19/2024 | 
| TCBI Texas Capital Bancshares | $59.27 -0.2%
 | 1/19/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $70.00 -> $68.00 | Low | View details for Wedbush rating of Texas Capital Bancshares (NASDAQ:TCBI) on 1/19/2024 | 
| IKNA Ikena Oncology | $1.40 
 | 1/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $8.00 | Low | View details for Wedbush rating of Ikena Oncology (NASDAQ:IKNA) on 1/19/2024 | 
| AMZN Amazon.com | $174.45 +2.7%
 | 1/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $210.00 | Low | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 1/19/2024 | 
| SMCI Super Micro Computer | $740.29 +6.1%
 | 1/19/2024 | Reiterated by | Wedbush | Analyst M. Bryson | Neutral -> Neutral | $250.00 | Low | View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 1/19/2024 | 
| JACK Jack in the Box | $77.27 +0.2%
 | 1/19/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $83.00 | Low | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 1/19/2024 | 
| VOR Vor Biopharma | $2.22 -3.5%
 | 1/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $11.00 | Low | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 1/18/2024 | 
| WTFC Wintrust Financial | $93.87 +1.4%
 | 1/18/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $110.00 | Low | View details for Wedbush rating of Wintrust Financial (NASDAQ:WTFC) on 1/18/2024 | 
| LOGI Logitech International | $85.21 +0.7%
 | 1/18/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $90.00 -> $92.00 | Low | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 1/18/2024 | 
| CFG Citizens Financial Group | $31.50 +0.4%
 | 1/18/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $36.00 -> $35.00 | Low | View details for Wedbush rating of Citizens Financial Group (NYSE:CFG) on 1/18/2024 | 
| SBUX Starbucks | $97.30 +0.7%
 | 1/18/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $100.00 -> $95.00 | Low | View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 1/18/2024 | 
| RGNX REGENXBIO | $16.21 -0.5%
 | 1/17/2024 | Reiterated by | Wedbush | - | Neutral | $21.00 | Low | View details for Wedbush rating of REGENXBIO (NASDAQ:RGNX) on 1/17/2024 | 
| SKX Skechers U.S.A. | $58.91 +1.6%
 | 1/17/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $62.00 -> $75.00 | Low | View details for Wedbush rating of Skechers U.S.A. (NYSE:SKX) on 1/17/2024 | 
| RCUS Arcus Biosciences | $15.81 +3.9%
 | 1/17/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $36.00 | Low | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 1/17/2024 | 
| KNTE Kinnate Biopharma | $2.29 -0.9%
 | 1/17/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Neutral -> Neutral | $2.00 | Low | View details for Wedbush rating of Kinnate Biopharma (NASDAQ:KNTE) on 1/17/2024 | 
| KMX CarMax | $74.79 +2.0%
 | 1/17/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $90.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 1/17/2024 | 
| XOS XOS | $8.02 +1.5%
 | 1/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of XOS (NASDAQ:XOS) on 1/16/2024 | 
| INFY Infosys | $20.10 -0.4%
 | 1/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of Infosys (NYSE:INFY) on 1/16/2024 | 
| WIT Wipro | $5.86 +0.2%
 | 1/16/2024 | Target Raised by | Wedbush | - | Underperform -> Underperform | $4.00 -> $6.00 | Low | View details for Wedbush rating of Wipro (NYSE:WIT) on 1/16/2024 | 
| TSLA Tesla | $193.57 +2.1%
 | 1/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $350.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 1/16/2024 | 
| ARDX Ardelyx | $9.74 +5.1%
 | 1/12/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $9.00 -> $13.00 | Low | View details for Wedbush rating of Ardelyx (NASDAQ:ARDX) on 1/12/2024 | 
| PRAX Praxis Precision Medicines | $45.49 +1.0%
 | 1/12/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $16.00 -> $29.00 | Low | View details for Wedbush rating of Praxis Precision Medicines (NASDAQ:PRAX) on 1/12/2024 | 
| APLS Apellis Pharmaceuticals | $68.56 +0.6%
 | 1/12/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $39.00 -> $60.00 | Low | View details for Wedbush rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 1/12/2024 | 
| KBH KB Home | $60.90 +0.4%
 | 1/11/2024 | Target Raised by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $55.00 -> $60.00 | Low | View details for Wedbush rating of KB Home (NYSE:KBH) on 1/11/2024 | 
| COIN Coinbase Global | $141.99 +7.1%
 | 1/11/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $110.00 -> $180.00 | Low | View details for Wedbush rating of Coinbase Global (NASDAQ:COIN) on 1/11/2024 | 
| PZZA Papa John's International | $72.49 -1.6%
 | 1/11/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $85.00 -> $87.00 | Low | View details for Wedbush rating of Papa John’s International (NASDAQ:PZZA) on 1/11/2024 | 
| WSM Williams-Sonoma | $219.99 +1.9%
 | 1/11/2024 | Upgraded by | Wedbush | Analyst S. Basham | Neutral -> Outperform | $175.00 -> $230.00 | Low | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 1/11/2024 | 
| GPN Global Payments | $136.00 -0.5%
 | 1/10/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $130.00 -> $160.00 | Low | View details for Wedbush rating of Global Payments (NYSE:GPN) on 1/10/2024 | 
| HD Home Depot | $363.15 -0.2%
 | 1/10/2024 | Upgraded by | Wedbush | Analyst S. Basham | Neutral -> Outperform | $330.00 -> $380.00 | Low | View details for Wedbush rating of Home Depot (NYSE:HD) on 1/10/2024 | 
| LSEA Landsea Homes | $12.02 -0.5%
 | 1/9/2024 | Reiterated by | Wedbush | - | Outperform | $16.00 | Low | View details for Wedbush rating of Landsea Homes (NASDAQ:LSEA) on 1/9/2024 | 
| COGT Cogent Biosciences | $5.88 -7.8%
 | 1/9/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Neutral |  | Low | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 1/9/2024 | 
| GEO The GEO Group | $11.56 -3.8%
 | 1/9/2024 | Reiterated by | Wedbush | - | Outperform | $14.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 1/9/2024 | 
| SRPT Sarepta Therapeutics | $126.87 -0.4%
 | 1/9/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $224.00 | Low | View details for Wedbush rating of Sarepta Therapeutics (NASDAQ:SRPT) on 1/9/2024 | 
| BLUE bluebird bio | $1.03 -1.9%
 | 1/8/2024 | Reiterated by | Wedbush | - | Neutral | $3.00 | Low | View details for Wedbush rating of bluebird bio (NASDAQ:BLUE) on 1/8/2024 | 
| BPMC Blueprint Medicines | $76.54 +3.2%
 | 1/8/2024 | Reiterated by | Wedbush | - | Outperform | $100.00 -> $97.00 | Low | View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 1/8/2024 | 
| IMNM Immunome | $23.11 -1.6%
 | 1/8/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Outperform | $12.00 | Low | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 1/8/2024 | 
| BEAM Beam Therapeutics | $29.05 +3.3%
 | 1/8/2024 | Reiterated by | Wedbush | - | Outperform | $48.00 | Low | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 1/8/2024 | 
| NVCR NovoCure | $15.31 +3.1%
 | 1/8/2024 | Reiterated by | Wedbush | - | Neutral | $21.00 | Low | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 1/8/2024 | 
|  | 
| ITOS iTeos Therapeutics | $10.72 +0.8%
 | 1/8/2024 | Reiterated by | Wedbush | - | Outperform | $33.00 | Low | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 1/8/2024 | 
| ORIC ORIC Pharmaceuticals | $12.66 +3.4%
 | 1/8/2024 | Reiterated by | Wedbush | - | Outperform | $12.00 | Low | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 1/8/2024 | 
| NUVL Nuvalent | $82.45 +2.3%
 | 1/8/2024 | Reiterated by | Wedbush | - | Outperform | $74.00 -> $82.00 | Low | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 1/8/2024 | 
| ASND Ascendis Pharma A/S | $141.75 +1.8%
 | 1/8/2024 | Reiterated by | Wedbush | - | Outperform | $202.00 -> $207.00 | Low | View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 1/8/2024 | 
| DOOR Masonite International | $130.51 +35.1%
 | 1/8/2024 | Reiterated by | Wedbush | - | Neutral | $92.00 | Low | View details for Wedbush rating of Masonite International (NYSE:DOOR) on 1/8/2024 | 
| SWTX SpringWorks Therapeutics | $46.96 +1.1%
 | 1/8/2024 | Reiterated by | Wedbush | - | Outperform | $45.00 | Low | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 1/8/2024 | 
| BANC Banc of California | $13.24 +2.2%
 | 1/3/2024 | Reiterated by | Wedbush | Analyst D. Chiaverini | Neutral |  | Low | View details for Wedbush rating of Banc of California (NYSE:BANC) on 1/3/2024 | 
| PCRX Pacira BioSciences | $28.78 +3.9%
 | 1/5/2024 | Reiterated by | Wedbush | - | Outperform | $57.00 | Low | View details for Wedbush rating of Pacira BioSciences (NASDAQ:PCRX) on 1/5/2024 | 
| SIMO Silicon Motion Technology | $68.46 +0.8%
 | 1/5/2024 | Reiterated by | Wedbush | - | Outperform | $85.00 | Low | View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 1/5/2024 | 
| STRO Sutro Biopharma | $4.69 -1.7%
 | 1/5/2024 | Reiterated by | Wedbush | - | Outperform | $12.00 | Low | View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 1/5/2024 | 
| KBH KB Home | $60.90 +0.4%
 | 1/5/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral | $55.00 | Low | View details for Wedbush rating of KB Home (NYSE:KBH) on 1/5/2024 | 
| GOEV Canoo | $0.16 -5.5%
 | 1/5/2024 | Initiated by | Wedbush | Analyst D. Ives | Outperform | $4.00 | Low | View details for Wedbush rating of Canoo (NYSE:GOEV) on 1/5/2024 | 
| NYCB New York Community Bancorp | $4.90 +16.9%
 | 1/4/2024 | Downgraded by | Wedbush | Analyst D. Chiaverini | Neutral -> Underperform |  | Low | View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 1/4/2024 | 
| ACET Adicet Bio | $3.27 -3.3%
 | 1/4/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | Low | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 1/4/2024 | 
| TCRX TScan Therapeutics | $5.81 -3.2%
 | 1/4/2024 | Reiterated by | Wedbush | - | Outperform | $9.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 1/4/2024 | 
| SRRK Scholar Rock | $15.40 -2.0%
 | 1/4/2024 | Reiterated by | Wedbush | - | Outperform | $23.00 | Low | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 1/4/2024 | 
| OMGA Omega Therapeutics | $3.86 +7.2%
 | 1/4/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $12.00 | Low | View details for Wedbush rating of Omega Therapeutics (NASDAQ:OMGA) on 1/4/2024 | 
| RVMD Revolution Medicines | $30.44 +0.2%
 | 1/4/2024 | Initiated by | Wedbush | Analyst R. Driscoll | Outperform | $41.00 | Low | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 1/4/2024 | 
| KROS Keros Therapeutics | $53.59 +4.5%
 | 1/3/2024 | Reiterated by | Wedbush | Analyst A. Argyrides | Outperform | $86.00 | Low | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 1/3/2024 | 
| NYCB New York Community Bancorp | $4.90 +16.9%
 | 1/3/2024 | Upgraded by | Wedbush | Analyst D. Chiaverini | Underperform -> Neutral | $8.00 | Low | View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 1/3/2024 | 
| KNSA Kiniksa Pharmaceuticals | $20.28 +6.6%
 | 1/2/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $23.00 -> $25.00 | Low | View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 1/2/2024 | 
| PFSI PennyMac Financial Services | $91.21 +1.0%
 | 1/2/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $85.00 -> $105.00 | Low | View details for Wedbush rating of PennyMac Financial Services (NYSE:PFSI) on 1/2/2024 | 
| WD Walker & Dunlop | $93.98 -1.0%
 | 1/2/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $110.00 -> $130.00 | Low | View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 1/2/2024 | 
| GTHX G1 Therapeutics | $4.53 -3.6%
 | 1/2/2024 | Reiterated by | Wedbush | - | Outperform | $5.00 | Low | View details for Wedbush rating of G1 Therapeutics (NASDAQ:GTHX) on 1/2/2024 | 
| FUSN Fusion Pharmaceuticals | $11.57 +2.2%
 | 1/2/2024 | Reiterated by | Wedbush | - | Outperform | $13.00 | Low | View details for Wedbush rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 1/2/2024 | 
| IRON Disc Medicine | $68.29 +2.3%
 | 1/2/2024 | Reiterated by | Wedbush | - | Outperform | $79.00 | Low | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 1/2/2024 | 
| TYRA Tyra Biosciences | $18.42 +0.9%
 | 12/29/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $27.00 | Low | View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 12/29/2023 | 
| MSFT Microsoft | $420.55 +1.6%
 | 12/28/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $425.00 -> $450.00 | Low | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 12/28/2023 | 
| ALIT Alight | $9.37 +1.5%
 | 12/28/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $11.00 -> $13.00 | Low | View details for Wedbush rating of Alight (NYSE:ALIT) on 12/28/2023 | 
| EXPE Expedia Group | $131.11 -17.8%
 | 12/27/2023 | Target Raised by | Wedbush | - | Neutral -> Neutral | $115.00 -> $130.00 | Low | View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 12/27/2023 | 
| CART Maplebear | $26.60 +2.0%
 | 12/27/2023 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $30.00 -> $26.00 | Low | View details for Wedbush rating of Maplebear (NASDAQ:CART) on 12/27/2023 | 
| LYFT Lyft | $13.03 +2.0%
 | 12/27/2023 | Target Raised by | Wedbush | - | Neutral -> Neutral | $12.00 -> $14.00 | Low | View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 12/27/2023 | 
| MELI MercadoLibre | $1,742.26 +0.5%
 | 12/27/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $1,700.00 -> $1,800.00 | Low | View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 12/27/2023 | 
| META Meta Platforms | $468.11 -0.4%
 | 12/27/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $350.00 -> $420.00 | Low | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 12/27/2023 | 
| PINS Pinterest | $36.87 -9.5%
 | 12/27/2023 | Target Raised by | Wedbush | - | Neutral -> Neutral | $32.00 -> $35.00 | Low | View details for Wedbush rating of Pinterest (NYSE:PINS) on 12/27/2023 | 
| BKNG Booking | $3,758.18 -2.1%
 | 12/27/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $3,300.00 -> $3,850.00 | Low | View details for Wedbush rating of Booking (NASDAQ:BKNG) on 12/27/2023 | 
| CTSH Cognizant Technology Solutions | $77.10 -1.5%
 | 12/26/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $75.00 -> $85.00 | Low | View details for Wedbush rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 12/26/2023 | 
| KRTX Karuna Therapeutics | $317.14 +0.3%
 | 12/22/2023 | Downgraded by | Wedbush | Analyst L. Chico | Outperform -> Neutral | $330.00 | Low | View details for Wedbush rating of Karuna Therapeutics (NASDAQ:KRTX) on 12/22/2023 | 
| TSLA Tesla | $193.57 +2.1%
 | 12/22/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $310.00 -> $350.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 12/22/2023 | 
| BROS Dutch Bros | $26.99 +2.3%
 | 12/21/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $35.00 -> $37.00 | Low | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 12/21/2023 | 
| LQDA Liquidia | $14.81 +0.9%
 | 12/21/2023 | Reiterated by | Wedbush | - | Underperform -> Underperform | $3.00 | Low | View details for Wedbush rating of Liquidia (NASDAQ:LQDA) on 12/21/2023 | 
| MU Micron Technology | $85.56 +0.8%
 | 12/21/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $95.00 | Low | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 12/21/2023 | 
| NFLX Netflix | $561.32 +0.5%
 | 12/21/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $525.00 | Low | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 12/21/2023 | 
| AMZN Amazon.com | $174.45 +2.7%
 | 12/21/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $180.00 -> $210.00 | Low | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 12/21/2023 | 
| WEN Wendy's | $19.32 +1.3%
 | 12/21/2023 | Downgraded by | Wedbush | Analyst N. Setyan | Outperform -> Neutral | $21.00 | Low | View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 12/21/2023 | 
| CMG Chipotle Mexican Grill | $2,638.35 +0.7%
 | 12/21/2023 | Downgraded by | Wedbush | Analyst N. Setyan | Outperform -> Neutral | $2,400.00 | Low | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 12/21/2023 | 
| CAKE Cheesecake Factory | $35.11 -1.5%
 | 12/21/2023 | Upgraded by | Wedbush | Analyst N. Setyan | Neutral -> Outperform | $34.00 -> $40.00 | Low | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 12/21/2023 | 
| CAVA CAVA Group | $52.88 +0.2%
 | 12/21/2023 | Upgraded by | Wedbush | Analyst N. Setyan | Neutral -> Outperform | $35.00 -> $48.00 | Low | View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 12/21/2023 | 
| KMX CarMax | $74.79 +2.0%
 | 12/20/2023 | Target Raised by | Wedbush | Analyst S. Basham | Overweight -> Overweight | $80.00 -> $90.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 12/20/2023 | 
| ASND Ascendis Pharma A/S | $141.75 +1.8%
 | 12/20/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $200.00 -> $202.00 | Low | View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 12/20/2023 | 
|  | 
| AAPL Apple | $188.85 +0.3%
 | 12/20/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 12/20/2023 | 
| GOSS Gossamer Bio | $0.87 +1.0%
 | 12/19/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 | Low | View details for Wedbush rating of Gossamer Bio (NASDAQ:GOSS) on 12/19/2023 | 
| IMNM Immunome | $23.11 -1.6%
 | 12/19/2023 | Initiated by | Wedbush | Analyst D. Nierengarten | Outperform | $12.00 | Low | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 12/19/2023 | 
| DRI Darden Restaurants | $167.66 -0.3%
 | 12/18/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $165.00 -> $177.00 | Low | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 12/18/2023 | 
| TPH Tri Pointe Homes | $35.14 -0.1%
 | 12/18/2023 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform -> Neutral | $32.00 | Low | View details for Wedbush rating of Tri Pointe Homes (NYSE:TPH) on 12/18/2023 | 
| TMHC Taylor Morrison Home | $53.91 +0.6%
 | 12/18/2023 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform -> Neutral | $52.00 | Low | View details for Wedbush rating of Taylor Morrison Home (NYSE:TMHC) on 12/18/2023 | 
| SKY Skyline Champion | $81.17 +2.1%
 | 12/18/2023 | Reiterated by | Wedbush | Analyst J. Mccanless | Outperform -> Neutral | $72.00 | Low | View details for Wedbush rating of Skyline Champion (NYSE:SKY) on 12/18/2023 | 
| MTH Meritage Homes | $154.42 -0.1%
 | 12/18/2023 | Downgraded by | Wedbush | Analyst J. Mccanless | Outperform -> Neutral | $170.00 | Low | View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 12/18/2023 | 
| DOOR Masonite International | $130.51 +35.1%
 | 12/18/2023 | Downgraded by | Wedbush | - | Outperform -> Neutral | $92.00 | Low | View details for Wedbush rating of Masonite International (NYSE:DOOR) on 12/18/2023 | 
| MHO M/I Homes | $122.35 0.0%
 | 12/18/2023 | Downgraded by | Wedbush | Analyst J. Mccanless | Outperform -> Neutral | $116.00 | Low | View details for Wedbush rating of M/I Homes (NYSE:MHO) on 12/18/2023 | 
| CCS Century Communities | $88.04 +0.7%
 | 12/18/2023 | Downgraded by | Wedbush | Analyst J. Mccanless | Outperform -> Neutral | $81.00 | Low | View details for Wedbush rating of Century Communities (NYSE:CCS) on 12/18/2023 | 
| EXLS ExlService | $30.94 +1.0%
 | 12/14/2023 | Reiterated by | Wedbush | - | Neutral -> Neutral | $34.00 | Low | View details for Wedbush rating of ExlService (NASDAQ:EXLS) on 12/14/2023 | 
| ACN Accenture | $371.67 +0.9%
 | 12/14/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $330.00 -> $360.00 | Low | View details for Wedbush rating of Accenture (NYSE:ACN) on 12/14/2023 | 
| PANW Palo Alto Networks | $376.90 +2.7%
 | 12/14/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $290.00 -> $350.00 | Low | View details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 12/14/2023 | 
| ETSY Etsy | $78.09 +4.8%
 | 12/14/2023 | Target Raised by | Wedbush | - | Neutral -> Neutral | $60.00 -> $90.00 | Low | View details for Wedbush rating of Etsy (NASDAQ:ETSY) on 12/14/2023 | 
| VICI VICI Properties | $29.72 +0.2%
 | 12/14/2023 | Reiterated by | Wedbush | - | Neutral -> Neutral | $30.00 | Low | View details for Wedbush rating of VICI Properties (NYSE:VICI) on 12/14/2023 | 
| TPX Tempur Sealy International | $50.60 -2.5%
 | 12/13/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $50.00 | Low | View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 12/13/2023 | 
| SLM SLM | $19.60 +0.5%
 | 12/13/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $18.00 -> $21.00 | Low | View details for Wedbush rating of SLM (NASDAQ:SLM) on 12/13/2023 | 
| COGT Cogent Biosciences | $5.88 -7.8%
 | 12/11/2023 | Downgraded by | Wedbush | Analyst D. Nierengarten | Outperform -> Neutral | $20.00 -> $5.00 | Low | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 12/11/2023 | 
| AAPL Apple | $188.85 +0.3%
 | 12/11/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $240.00 -> $250.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 12/11/2023 | 
| TXRH Texas Roadhouse | $134.73 -0.6%
 | 12/11/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $120.00 | Low | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 12/11/2023 | 
| WD Walker & Dunlop | $93.98 -1.0%
 | 12/11/2023 | Target Raised by | Wedbush | - | Outperform | $90.00 -> $110.00 | Low | View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 12/11/2023 | 
| LULU Lululemon Athletica | $470.24 -0.6%
 | 12/8/2023 | Target Raised by | Wedbush | - | Outperform | $420.00 -> $503.00 | Low | View details for Wedbush rating of Lululemon Athletica (NASDAQ:LULU) on 12/8/2023 | 
| SHOP Shopify | $90.72 +3.2%
 | 12/6/2023 | Reiterated by | Wedbush | Analyst S. Devitt | Outperform -> Neutral | $66.00 -> $68.00 | Low | View details for Wedbush rating of Shopify (NYSE:SHOP) on 12/6/2023 | 
| VRDN Viridian Therapeutics | $18.52 +3.1%
 | 12/4/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $37.00 | Low | View details for Wedbush rating of Viridian Therapeutics (NASDAQ:VRDN) on 12/4/2023 | 
| MLTX MoonLake Immunotherapeutics | $63.19 +3.2%
 | 12/1/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $92.00 | Low | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 12/1/2023 | 
| ARDX Ardelyx | $9.74 +5.1%
 | 12/1/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $9.00 | Low | View details for Wedbush rating of Ardelyx (NASDAQ:ARDX) on 12/1/2023 | 
| CROX Crocs | $107.54 +3.1%
 | 12/1/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $96.00 -> $120.00 | Low | View details for Wedbush rating of Crocs (NASDAQ:CROX) on 12/1/2023 | 
| DECK Deckers Outdoor | $845.22 +1.5%
 | 12/1/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $650.00 -> $705.00 | Low | View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 12/1/2023 | 
| CVNA Carvana | $53.13 +1.4%
 | 12/1/2023 | Reiterated by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $40.00 | Low | View details for Wedbush rating of Carvana (NYSE:CVNA) on 12/1/2023 | 
| ASO Academy Sports and Outdoors | $68.01 +2.5%
 | 12/1/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $60.00 | Low | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 12/1/2023 | 
| AMZN Amazon.com | $174.45 +2.7%
 | 12/1/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $180.00 | Low | View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 12/1/2023 | 
| ESTC Elastic | $130.39 +3.0%
 | 12/1/2023 | Reiterated by | Wedbush | - | Neutral -> Neutral | $67.00 | Low | View details for Wedbush rating of Elastic (NYSE:ESTC) on 12/1/2023 | 
| TXRH Texas Roadhouse | $134.73 -0.6%
 | 12/1/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $110.00 -> $120.00 | Low | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 12/1/2023 | 
| GME GameStop | $14.66 +2.2%
 | 11/30/2023 | Reiterated by | Wedbush | - | Underperform -> Underperform | $6.00 | Low | View details for Wedbush rating of GameStop (NYSE:GME) on 11/30/2023 | 
| ABR Arbor Realty Trust | $12.33 +1.7%
 | 11/30/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Arbor Realty Trust (NYSE:ABR) on 11/30/2023 | 
| PVH PVH | $127.76 +0.6%
 | 11/30/2023 | Reiterated by | Wedbush | - | Neutral -> Neutral | $88.00 | Low | View details for Wedbush rating of PVH (NYSE:PVH) on 11/30/2023 | 
| WOOF Petco Health and Wellness | $2.62 +2.7%
 | 11/30/2023 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $4.50 -> $3.50 | Low | View details for Wedbush rating of Petco Health and Wellness (NASDAQ:WOOF) on 11/30/2023 | 
| PSTG Pure Storage | $44.75 +1.4%
 | 11/30/2023 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $45.00 -> $40.00 | Low | View details for Wedbush rating of Pure Storage (NYSE:PSTG) on 11/30/2023 | 
| GM General Motors | $38.56 -0.2%
 | 11/30/2023 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $46.00 -> $40.00 | Low | View details for Wedbush rating of General Motors (NYSE:GM) on 11/30/2023 | 
| CRM Salesforce | $291.30 -0.2%
 | 11/30/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $255.00 -> $280.00 | Low | View details for Wedbush rating of Salesforce (NYSE:CRM) on 11/30/2023 | 
| OKTA Okta | $87.85 +3.7%
 | 11/30/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $90.00 | Low | View details for Wedbush rating of Okta (NASDAQ:OKTA) on 11/30/2023 | 
| ANAB AnaptysBio | $23.01 -0.5%
 | 11/29/2023 | Reiterated by | Wedbush | - | Neutral -> Neutral | $20.00 | Low | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 11/29/2023 | 
| TOL Toll Brothers | $101.01 +0.7%
 | 11/29/2023 | Reiterated by | Wedbush | - | Neutral -> Neutral | $82.00 | Low | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 11/29/2023 | 
| SHOO Steven Madden | $41.75 +1.9%
 | 11/29/2023 | Reiterated by | Wedbush | - | Neutral -> Neutral | $36.00 | Low | View details for Wedbush rating of Steven Madden (NASDAQ:SHOO) on 11/29/2023 | 
| BLDR Builders FirstSource | $185.33 +0.0%
 | 11/29/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $175.00 | Low | View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 11/29/2023 | 
| SKX Skechers U.S.A. | $58.91 +1.6%
 | 11/29/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $59.00 -> $62.00 | Low | View details for Wedbush rating of Skechers U.S.A. (NYSE:SKX) on 11/29/2023 | 
| AZO AutoZone | $2,680.00 -1.9%
 | 11/29/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $2,750.00 | Low | View details for Wedbush rating of AutoZone (NYSE:AZO) on 11/29/2023 | 
| NTAP NetApp | $89.85 +1.0%
 | 11/29/2023 | Target Raised by | Wedbush | - | Neutral -> Neutral | $75.00 -> $85.00 | Low | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 11/29/2023 | 
| CRNC Cerence | $16.67 +5.5%
 | 11/28/2023 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $31.00 -> $19.00 | N/A | View details for Wedbush rating of Cerence (NASDAQ:CRNC) on 11/28/2023 | 
| TSLA Tesla | $193.57 +2.1%
 | 11/28/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $310.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 11/28/2023 | 
| ZS Zscaler | $254.93 +2.2%
 | 11/28/2023 | Target Raised by | Wedbush | - | Outperform -> Outperform | $185.00 -> $210.00 | Low | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 11/28/2023 | 
| CRWD CrowdStrike | $329.34 +2.0%
 | 11/28/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $200.00 | Low | View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 11/28/2023 | 
| AAPL Apple | $188.85 +0.3%
 | 11/24/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $240.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 11/24/2023 | 
| ASO Academy Sports and Outdoors | $68.01 +2.5%
 | 11/22/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $60.00 | Low | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 11/22/2023 | 
| LOW Lowe's Companies | $222.26 +0.8%
 | 11/22/2023 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $230.00 -> $215.00 | Low | View details for Wedbush rating of Lowe’s Companies (NYSE:LOW) on 11/22/2023 | 
| DKS DICK'S Sporting Goods | $162.17 +1.4%
 | 11/22/2023 | Target Raised by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $115.00 -> $130.00 | Low | View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 11/22/2023 | 
| BBY Best Buy | $75.60 +0.1%
 | 11/22/2023 | Reiterated by | Wedbush | - | Neutral -> Neutral | $70.00 | Low | View details for Wedbush rating of Best Buy (NYSE:BBY) on 11/22/2023 | 
| MSFT Microsoft | $420.55 +1.6%
 | 11/22/2023 | Reiterated by | Wedbush | - | Outperform -> Outperform | $425.00 | Low | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 11/22/2023 | 
| DNTH Dianthus Therapeutics | $23.94 +3.2%
 | 11/22/2023 | Initiated by | Wedbush | Analyst L. Chico | Outperform | $23.00 | Low | View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 11/22/2023 |